BUSINESS
Novo CEO tells CNBC why drugmaker is rebranding, needs to 'rethink' obesity strategy
CNBC BusinessMonday, September 14, 2026 at 5:30 PM
RedScroll Brief
The Danish drugmaker called the changes the beginning of a new chapter for the company, which faces stiff competition from Eli Lilly.
RedScroll Signal
- Impact
- High
- Category
- Business
- Market relevance
- High
- Why it matters
- Corporate and market moves reprice risk and reveal where power and cash are concentrating. The Danish drugmaker called the changes the beginning of a new chapter for the company, which faces stiff competition from Eli Lilly. Investors will watch earnings, rates, and competitive positioning connected to Novo and Business.
Desk copy
RedScroll Briefing
Extractive editorial brief — not a reprint of the original
What happened
The Danish drugmaker called the changes the beginning of a new chapter for the company, which faces stiff competition from Eli Lilly.
Why it matters
Corporate and market moves reprice risk and reveal where power and cash are concentrating.
Background
CNBC Business reported on this under business. RedScroll surfaces the signal with an extractive brief — not a reprint of the original article. Read the source for full reporting.
Timeline
CNBC Business published: Novo CEO tells CNBC why drugmaker is rebranding, needs to 'rethink' obesity strategy
Story is in today’s RedScroll edition. Follow the original source for updates.
Economic impact
Investors will watch earnings, rates, and competitive positioning connected to Novo and Business.
More on
Related stories
- AI staff 'genuinely frightened' for humanity's future, ex-Anthropic researcher tells BBC
BBC BusinessBUSINESS
- Should Anthropic press pause on a potential $2trn IPO?
The Economist BusinessBUSINESS
- How an oil-supply crisis could bring about an investment boom
The Economist BusinessBUSINESS
- Are you committed to your company or your team?
The Economist BusinessBUSINESS
- Global Impact of AI 'Apocalypse'
Bloomberg MarketsBUSINESS
- Apollo’s Michaels Uses $101 Million of Tariff Refund to Cut Debt
Bloomberg MarketsBUSINESS
Source
CNBC Business
Original reporting by CNBC Business. RedScroll provides an extractive briefing only.